Viewing Study NCT00527657


Ignite Creation Date: 2025-12-24 @ 6:52 PM
Ignite Modification Date: 2026-01-02 @ 10:07 AM
Study NCT ID: NCT00527657
Status: COMPLETED
Last Update Posted: 2018-11-14
First Post: 2007-09-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module